| Q35801636 | Antibodies Directed against Shiga-Toxin Producing Escherichia coli Serotype O103 Type III Secreted Proteins Block Adherence of Heterologous STEC Serotypes to HEp-2 Cells |
| Q38807872 | Challenges in Veterinary Vaccine Development and Immunization |
| Q41878712 | EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7. |
| Q44957575 | Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development |
| Q84878018 | Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge |
| Q59274684 | Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7 |
| Q35575370 | In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications |
| Q36035612 | Inhibition of Adhesion of Enteropathogenic Escherichia coli to HEp-2 Cells by Binding of a Novel Peptide to EspB Protein |
| Q28492629 | Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa |
| Q30431366 | Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria |
| Q37699502 | Oral Immunization with Recombinant Lactobacillus acidophilus Expressing espA-Tir-M Confers Protection against Enterohemorrhagic Escherichia coli O157:H7 Challenge in Mice |
| Q34011259 | The type III secretion system tip complex and translocon. |
| Q36969851 | Type III secretion systems and disease |